Global Eligard marketing partners

Tolmar is a specialty pharmaceutical company that develops, manufactures, and commercializes high-value therapies, primarily focused on urology and oncology. The company's flagship product is Eligard (leuprolide acetate), a treatment for advanced prostate cancer that utilizes the proprietary ATRIGEL delivery system for sustained release. Tolmar manages the global commercialization of Eligard through a network of strategic marketing partners, including Recordati for Europe and international markets, TerSera Therapeutics for the United States, and Knight Therapeutics for Canada. Beyond its commercial portfolio, Tolmar maintains robust in-house R&D and GMP-compliant manufacturing facilities in Northern Colorado. The company is also active in the development of complex generic injectables and other specialty branded products like Atridox for periodontal disease.